[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Deafness & Hearing Loss |
|
|
Clinical Trial: Safety & Efficacy of Toremifene Citrate for Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy
This study is currently recruiting patients.
Verified by GTx August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Prostate Cancer Osteoporosis Bone Loss Fractures | Drug: Toremifene Citrate | Phase III |
MedlinePlus related topics: Fractures; Osteoporosis; Prostate Cancer
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Safety/Efficacy Study
Official Title: A Randomized, Double Blind, Placebo Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
Secondary Outcomes: Percentage of subjects with at least one new or worsening vertebral fracture at 24 months; Percentage of subjects with a clinical fragility fracture at 12 and 24 months; Percent change from baseline in lumbar BMD as measured by DEXA scan at 24 months
Expected Total Enrollment: 1200
Study start: October 2003
Last follow-up: September 2007; Data entry closure: January 2008
Eligibility
Inclusion Criteria:
- To be eligible for participation in this study, subjects must meet all of the following criteria (minor deviations may be discussed with the medical monitor for possible inclusions):
• Give voluntary, signed informed consent in accordance with institutional policies • Be male, aged ≥ 50 years • Have histologically documented prostate cancer. Subjects with metastatic prostate cancer may still be considered for the study as long as they are not disqualified by other inclusion/exclusion criteria and there is a reasonable expectation that their medical condition will not interfere with the objectives of the study and that adequate follow-up and compliance with the study protocol can be achieved for the full 24-month duration of the study.
• Have been on a) ADT treatment (either LHRHa or orchiectomy) for at least 6 months. Or b) Intermittent LHRHa for at least the preceding 12 months is acceptable, but subjects must be maintained on uninterrupted treatment for the duration of this study once they are randomized into the study.
• a) Be aged ≥ 70 years or b) have BMD of lumbar spine or femoral neck at or below the specified thresholds for study entry
BMD Threshold Hologic BMD (g/cm2) Lunar BMD (g/cm2) L1-L4 0.926 1.050 Femoral Neck 0.717 0.840
• Serum PSA ≤ 4 ng/mL • Have a Zubrod performance status ≤ 1 (See Appendix B) • Subject weight < 300 lbs (weight limitation of DEXA equipment) • Agree to complete a daily diary of medication intake and to provide tablet containers for accurate counts • Agree to use an effective method of contraception, if the partner is of childbearing age, while on study • Have adequate bone marrow, liver and renal function: White Blood Cell (WBC) Count ≥ 3,000/mm3 Platelet Count ≥ 100,000/mm3 Bilirubin ≤ 1.5 mg/dL AST and ALT < 2x upper limit of normal Serum Creatinine ≤ 2.0 mg%
Exclusion Criteria:
- Subjects with any of the following will not be eligible for enrollment:
• Taking bisphosphonates, SERMs, PTH, Forteo® (teriparatide), calcitonin, or oral glucocorticoids within 45 days of randomization • Have any disease or condition that would preclude an accurate evaluation of radiographs of the thoracic and lumbar spine (at least eight evaluable vertebrae in the range T4 to L4) (for example, severe scoliosis, or sequelae of orthopedic procedures or other surgery) • Have > 4 vertebral fragility fractures • Have any history of other carcinomas within the last 5 years (except nonmelanoma cutaneous malignancies and superficial bladder cancer with no evidence of recurrence which will not be excluded).
NOTE: Patients with cancers other than nonmelanoma cutaneous malignancies and superficial bladder cancer with no evidence of tumor recurrence for at least 5 years after definitive treatment will not be excluded from this study.
• Have Paget’s disease of bone • Have active systemic viral, bacterial or fungal infections requiring treatment • Have, in the judgment of the investigator, a clinically significant concurrent illness or psychological, familial, sociological, geographical or other concomitant condition that would not permit adequate follow-up and compliance with the study protocol for the full 24-month duration of the study • Received treatment with other investigational agents within 30 days prior to randomization • Taking finasteride (e.g., Proscar®), dutasteride (e.g., Avodart®), Danocrine® (danazol) or testosterone-like supplements, such as dehydroepiandrosterone (DHEA) (subject is eligible if he stops these agents for a total washout of 45 days prior to randomization and agrees not to use these agents for the duration of the study) • Taking herbal medicine or dietary supplements for prostate health, such as PC SPES and Saw Palmetto (also known as Seronea Pepens) (subject is eligible if he stops these agents for a total washout of 45 days prior to randomization and agrees not to use these agents for the duration of the study). Lycopene and selenium are not prohibited and no washout is required.
• Have a history of thromboembolic disease including deep vein thrombosis or pulmonary embolus • Have a history of chronic hepatitis or cirrhosis • Have received prior treatment with toremifene
Location and Contact Information
Leslie D Gooch, BS/CCRP 901-523-9700 Ext. 193 lgoochharris@gtxinc.com
Alabama
Urology Centers of Alabama, Homewood, Alabama, 35209, United States; Recruiting
Walter Pittman, MD, Principal Investigator
Coastal Clinical Research, Mobile, Alabama, 36608, United States; Recruiting
Charles White, MD, Principal Investigator
Arkansas
Arkansas Urology, Little Rock, Arkansas, 72211, United States; Recruiting
J. Walt Stallings, MD, Principal Investigator
California
Center of Urologic Research, La Mesa, California, 91942, United States; Recruiting
Mohamed Bidair, MD, Principal Investigator
Pacific Clinical Research, Santa Monica, California, 90404, United States; Recruiting
Stanley Brosman, MD, Principal Investigator
San Bernadino Urological Associates, San Bernadino, California, 92404, United States; Recruiting
Franklin Chu, Principal Investigator
Veterans Medical Research Foundation, San Diego, California, 92161, United States; Recruiting
Tracy Downs, MD, Principal Investigator
West Coast Clinical Research, Tarzana, California, 91356, United States; Recruiting
Eugene Dula, MD, Principal Investigator
Urological Physicians of San Diego, San Diego, California, 92103, United States; Recruiting
Danny Keiller, MD, Principal Investigator
Urological Sciences Research Foudation, Culver City, California, 90232, United States; Recruiting
Leonard Marks, MD, Principal Investigator
Palo Alto VA, Palo Alto, California, 94305, United States; Recruiting
Stewart McCallum, MD, Principal Investigator
Urological Associates of Central CA, Fresno, California, 93720, United States; Recruiting
William Schiff, MD, Principal Investigator
Advanced Urology Medical Center Clinical Trials, Anaheim, California, 92801, United States; Recruiting
Alfred Sidhom, MD, Principal Investigator
South Orange County Medical Research Center, Laguna Woods, California, 92653, United States; Recruiting
Jay Young, MD, Principal Investigator
Western Clinical Research, Inc., Torrance, California, 90505, United States; Recruiting
Norman Zinner, MD, Principal Investigator
Colorado
Urology Associates, Denver, Colorado, 80210, United States; Recruiting
Barrett Cowan, MD, Principal Investigator
Western Urological Research, Wheat Ridge, Colorado, 80033, United States; Recruiting
Lawrence Karsh, MD, Principal Investigator
Connecticut
Connecticut Clinical Research, Waterbury, Connecticut, 06708, United States; Recruiting
Robert Feldman, MD, Principal Investigator
Urologic Center, New Haven, Connecticut, 06511, United States; Recruiting
Stanton Honig, MD, Principal Investigator
Urological Associates of Bridgeport, Trumball, Connecticut, 06611, United States; Recruiting
Arthur Pinto, MD, Principal Investigator
District of Columbia
Walter Reed Army Medical Center, Washington, District of Columbia, 20307, United States; Recruiting
David McLeod, MD, Principal Investigator
Florida
UroSearch, Tavares, Florida, 32778, United States; Recruiting
Charles Cartwright, MD, Principal Investigator
Central Florida Urology Group/ UroSearch, Ocala, Florida, 34474, United States; Recruiting
David Cunningham, MD, Principal Investigator
Atlantic Urological Associates, Daytona Beach, Florida, 32114, United States; Recruiting
Martin Dineen, MD, Principal Investigator
Tampa Bay Urology, Tampa, Florida, 33607, United States; Recruiting
Todd Fusia, MD, Principal Investigator
South Florida Medical Research, Aventura, Florida, 33180, United States; Recruiting
Marc Gittleman, MD, Principal Investigator
Pinellas Urology, St. Petersburg, Florida, 33710, United States; Recruiting
Sean Heron, MD, Principal Investigator
Lakeland Regional Medical Center, Lakeland, Florida, 33805, United States; Recruiting
Byron Hodge, MD, Principal Investigator
Winter Park Urology Associates, Orlando, Florida, 32803, United States; Recruiting
David Jablonski, MD, Principal Investigator
Panama City Urology, Panama City Beach, Florida, 32405, United States; Recruiting
Mike Jenkins, MD, Principal Investigator
Florida Foundation for Healthcare Research, Ocala, Florida, 34474, United States; Recruiting
Ira Klimberg, MD, Principal Investigator
Cleveland Clinic-Florida, Weston, Florida, 33331, United States; Recruiting
Nicholas Muruve, MD, Principal Investigator
Southeastern Research Group, Tallahassee, Florida, 32308, United States; Recruiting
Raleigh Rollins, MD, Principal Investigator
Advance Research Institute, New Port Richey, Florida, 34652, United States; Recruiting
Jerrold Sharkey, MD, Principal Investigator
Urosearch, Inverness, Florida, 34452, United States; Recruiting
Thomas Stringer, MD, Principal Investigator
Urology Consultants Inc., Clearwater, Florida, 33761, United States; Recruiting
James M Zachary, MD, Principal Investigator
Georgia
Midtown Urology, Atlanta, Georgia, 30308, United States; Recruiting
James K Bennett, MD, Principal Investigator
Augusta VAMC, Augusta, Georgia, 30912, United States; Recruiting
James A. Brown, MD, Principal Investigator
Harbin Clinic Department of Urology Research, Rome, Georgia, 30165, United States; Recruiting
James Crane, Principal Investigator
Southeastern Medical Research Institute, Columbus, Georgia, 31904, United States; Recruiting
William Harper, MD, Principal Investigator
Georgia Urology, Atlanta, Georgia, 30342, United States; Recruiting
Emerson Harrison, MD, Principal Investigator
North Fulton Urology, Roswell, Georgia, 30076, United States; Recruiting
Lewis Kriteman, MD, Principal Investigator
St. Joseph''''s, Candler Health System, Savannah, Georgia, 31405, United States; Recruiting
Richard Mazo, MD, Principal Investigator
Urology Enterprises, Marietta, Georgia, 30060, United States; Recruiting
Ronald Roper, MD, Principal Investigator
St. Joseph Research Institute, Atlanta, Georgia, 30342, United States; Recruiting
Holt Sanders, MD, Principal Investigator
Idaho
North Idaho Urology, Coeur D Alene, Idaho, 83814, United States; Recruiting
Randil Clark, MD, Principal Investigator
Illinois
Special Care Research, Peoria, Illinois, 61614, United States; Recruiting
Giovanni Columbo, MD, Principal Investigator
Prairie Medical Associates, Chicago, Illinois, 60616, United States; Recruiting
Terry Mason, MD, Principal Investigator
Medical and Surgical Specialists, Galesburg, Illinois, 61401, United States; Recruiting
Thomas Patterson, MD, Principal Investigator
Indiana
Metropolitan Urology, Jeffersonville, Indiana, 47130, United States; Recruiting
James Bailen, MD, Principal Investigator
Urology of Indiana, LLC, Greenwood, Indiana, 46143, United States; Recruiting
Terry Jones, MD, Principal Investigator
MMPC Urology, Greenwood, Indiana, 49546, United States; Recruiting
Richard Kahnoski, MD, Principal Investigator
Kansas
Heartland Research Associates, LLC, Wichita, Kansas, 67207, United States; Recruiting
Terry Poling, MD, Principal Investigator
Louisiana
Regional Urology LLC, Shreveport, Louisiana, 71106, United States; Recruiting
David Price, MD, Principal Investigator
LSUHSC/Stanley Scott Cancer Center, New Orleans, Louisiana, 70112, United States; Recruiting
Oliver Sartor, MD, Principal Investigator
Maryland
Urology Center, PA, Hagerstown, Maryland, 21742, United States; Recruiting
Kevin Hackett, MD, Principal Investigator
Maryland Prostate Center: University of Maryland Medical Center, Baltimore, Maryland, 21201, United States; Recruiting
Michael Naslund, MD, Principal Investigator
Anne Arundel Urology P.A., Annapolis, Maryland, 21401, United States; Recruiting
Eric Schwartz, MD, Principal Investigator
Mid Atlantic Clinical Research, Rockville, Maryland, 28050, United States; Recruiting
Jonathan White, MD, Principal Investigator
Massachusetts
The Fallon Clinic, Worcester, Massachusetts, 01605, United States; Recruiting
Mitchell Bamberger, MD, Principal Investigator
Wayne Glazier, Worcester, Massachusetts, 01605, United States; Recruiting
Wayne Glazier, MD, Principal Investigator
Michigan
Beaumont Medical, Royal Oak, Michigan, 48073, United States; Recruiting
Ananias Diokno, MD, Principal Investigator
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States; Recruiting
Ken Pienta, MD, Principal Investigator
Minnesota
Park Nicollet Urology, St. Louis Park, Minnesota, 55416, United States; Recruiting
William Borkon, MD, Principal Investigator
Mayo Clinic Urology Department, Rochester, Minnesota, 55905, United States; Recruiting
Ajay Nehra, MD, Principal Investigator
Missouri
Urologic Research Center, St. Louis, Missouri, 63141, United States; Not yet recruiting
Arnold Bullock, MD, Principal Investigator
PPS Clinical Research, St. Louis, Missouri, 63141, United States; Recruiting
Jay Patel, MD, Principal Investigator
Kansas City Urology, PC, Kansas, Missouri, 64131, United States; Recruiting
Brandon Pomeroy, MD, Principal Investigator
Nevada
Sheldon Freeman, Las Vegas, Nevada, 89109, United States; Recruiting
Sheldon Freedman, MD, Principal Investigator
Urologic Surgeons, Ltd., Reno, Nevada, 89502, United States; Not yet recruiting
John Scott, MD, Principal Investigator
New Jersey
Urology Healthcare Associates, Willingboro, New Jersey, 08046, United States; Recruiting
Scott Asroff, MD, Principal Investigator
Coastal Urology Associates, Brick, New Jersey, 08724, United States; Recruiting
Daniel Burzon, MD, Principal Investigator
Lawrenceville Urology Associates, Lawrenceville, New Jersey, 08648, United States; Recruiting
Gary S Karlin, MD, Principal Investigator
Hamilton Urology PA, Hamilton, New Jersey, 08690, United States; Recruiting
Earl Linder, MD, Principal Investigator
Assoc. Urologic Specialists, Marlton, New Jersey, 08053, United States; Recruiting
Neil Phillips, MD, Principal Investigator
New Mexico
Urology Group of New Mexico, Albuquerque, New Mexico, 87109, United States; Recruiting
Frederick Snoy, MD, Principal Investigator
New York
Center for Urologic Research WNY, LLC, Williamsville, New York, 14221, United States; Recruiting
Phillip Aliotta, MD, Principal Investigator
Metropolitan Urologic Services, PC, Elmont, New York, 11003, United States; Recruiting
Carlton Barnswell, MD, Principal Investigator
Urological Surgeons of Long Island, Garden City, New York, 11530, United States; Recruiting
Robert Edelman, MD, Principal Investigator
Urology Inst. Of New York, Albany, New York, 12208, United States; Recruiting
Hugh Fisher, MD, Principal Investigator
Mount Sinai School of Medicine, New York, New York, 10029, United States; Recruiting
Simon Hall, MD, Principal Investigator
Staten Island Urological Research , PC, Staten Island, New York, 10304, United States; Recruiting
Ron Israeli, MD, Principal Investigator
University Urology Associates, New York, New York, 10016, United States; Recruiting
Jed Kaminetsky, MD, Principal Investigator
Associated Urologists of CNY, Syracuse, New York, 13210, United States; Recruiting
Joel Bass, MD, Principal Investigator
William Oberheim, Albany, New York, 12208, United States; Recruiting
William Oberheim, MD, Principal Investigator
CNY Urology, Oneida, New York, 13421, United States; Recruiting
Basha Omarbasha, MD, Principal Investigator
North Carolina
University of North Carolina, Chapel Hill, North Carolina, 27559, United States; Recruiting
Cully Carson, MD, Principal Investigator
Piedmont Medical Research Associates, Winston Salem, North Carolina, 27103, United States; Recruiting
David Cook, MD, Principal Investigator
Asheboro Urology, Asheboro, North Carolina, 27203, United States; Recruiting
Prithivi Hanspal, MD, Principal Investigator
Wake Urology, Raleigh, North Carolina, 27607, United States; Recruiting
Richard Kane, MD, Principal Investigator
The Urology Center, Greensboro, North Carolina, 27403, United States; Recruiting
Sigmund Tannenbaum, MD, Principal Investigator
North Dakota
Odyssey Research, Bismarck, North Dakota, 58501, United States; Recruiting
Leslie Rainwater, MD, Principal Investigator
Ohio
Southwest Urology, Parma, Ohio, 44129, United States; Recruiting
Michael Berte, MD, Principal Investigator
Colombus Urology Research, Columbus, Ohio, 43214, United States; Recruiting
David H. Brown, MD, Principal Investigator
Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, 44195, United States; Recruiting
Robert Dreicer, MD, Principal Investigator
The Urology Group, Cincinnati, Ohio, 45212, United States; Recruiting
William Monnig, MD, Principal Investigator
Summa Health Care, Akron, Ohio, 44304, United States; Recruiting
Michael ` Seider, MD, Principal Investigator
Urology of Northern Ohio, Elyria, Ohio, 44035, United States; Recruiting
J.P. Spirnak, MD, Principal Investigator
Oklahoma
Oklahoma University Medical Center, Oklahoma City, Oklahoma, 73104, United States; Recruiting
Daniel Culkin, MD, Principal Investigator
Urologic Specialists of Oklahoma, Inc., Tulsa, Oklahoma, 12208, United States; Recruiting
John Forrest, MD, Principal Investigator
Oregon
The Corvallis Clinic, Corvallis, Oregon, 97330, United States; Recruiting
Peter Kenyon, MD, Principal Investigator
Oregon Urology Specialists, Springfield, Oregon, 97477, United States; Recruiting
Bryan Mehlhaff, MD, Principal Investigator
Pennsylvania
Urologic Surgery, Bala Cynwyd, Pennsylvania, 19004, United States; Recruiting
Lawrence Belkoff, MD, Principal Investigator
The Urology Institute, Monroeville, Pennsylvania, 15146, United States; Recruiting
Frank Costa, MD, Principal Investigator
State College Urologic Association, State College, Pennsylvania, 16801, United States; Recruiting
Charles Dalton, MD, Principal Investigator
University of Pittsburg, Pittsburg, Pennsylvania, 15232, United States; Recruiting
Jeff Gingrich, MD, Principal Investigator
Ginsberg and Harkaway Urology, Philadelphia, Pennsylvania, 19141, United States; Recruiting
Phillip Ginsberg, MD, Principal Investigator
University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States; Recruiting
Bruce Malkowicz, MD, Principal Investigator
Urologic Associates of Allentown, Allentown, Pennsylvania, 18103, United States; Recruiting
Brian Murphy, MD, Principal Investigator
University of Pittsburgh, Pittsburgh, Pennsylvania, 15232, United States; Recruiting
Joel Nelson, MD, Principal Investigator
Urological Associates of Lancaster, Ltd., Lancaster, Pennsylvania, 17604, United States; Recruiting
Paul Sieber, MD, Principal Investigator
Rhode Island
University Urological Research Institute, Providence, Rhode Island, 02904, United States; Recruiting
Barry Stein, MD, Principal Investigator
South Carolina
Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States; Recruiting
Brian Roberts, MD, Principal Investigator
Radiant Research, Greer, South Carolina, 29651, United States; Recruiting
John Walton, MD, Principal Investigator
Tennessee
Urology Associates, Nashville, Tennessee, 37209, United States; Recruiting
David Bilhartz, MD, Principal Investigator
Vanderbilt Medical Center, Nashville, Tennessee, 37232, United States; Recruiting
Michael Cookson, MD, Principal Investigator
Volunteer Research Group, Knoxville, Tennessee, 37920, United States; Recruiting
Paul Hatcher, MD, Principal Investigator
Center for Urological Treatment, Nashville, Tennessee, 37203, United States; Recruiting
Dean Knoll, MD, Principal Investigator
Southeast Urology Network, Memphis, Tennessee, 38119, United States; Recruiting
Mark Saslawsky, MD, Principal Investigator
Ace Research Specialists, Nashville, Tennessee, 37203, United States; Recruiting
Michael Spalding, MD, Principal Investigator
Texas
Professional Quality Research, Austin, Texas, 78756, United States; Recruiting
Richard Chopp, MD, Principal Investigator
Breco Research, Houston, Texas, 77024, United States; Recruiting
Mark Kalish, MD, Principal Investigator
Scott and White Clinical Hospital, Temple, Texas, 76508, United States; Recruiting
Belur Patel, MD, Principal Investigator
Urology San Antonio Research, PA, San Antonio, Texas, 78229, United States; Recruiting
Daniel Saltzstein, MD, Principal Investigator
Urology Consultants, PA, San Antonio, Texas, 78229, United States; Recruiting
Sammy Vick, MD, Principal Investigator
Utah
Salt Lake City Research, Salt Lake City, Utah, 84124, United States; Recruiting
Lane Childs, MD, Principal Investigator
Virginia
Devine Tidewater Urology, Norfolk, Virginia, 23502, United States; Recruiting
Robert Given, MD, Principal Investigator
McGuire VA Medical Center, Richmond, Virginia, 23249, United States; Recruiting
Mayer Grob, MD, Principal Investigator
Med Atlantic, Inc (Virginia Urology), Richmond, Virginia, 23235, United States; Recruiting
James McMurtry, MD, Principal Investigator
Adult and Pediatric Urologist of Northern VA, Alexandria, Virginia, 22304, United States; Recruiting
George Tawil, MD, Principal Investigator
Washington
Deaconess Medical Center, Spokane, Washington, 99204, United States; Recruiting
Thomas Fairchild, MD, Principal Investigator
Seattle VAMC, Seattle, Washington, 98108, United States; Recruiting
Daniel Lin, MD, Principal Investigator
Madigan Army Medical Center, Tacoma, Washington, 98431, United States; Recruiting
Keith O''''Reilly, MD, Principal Investigator
Wisconsin
Froedtert Memorial Lutheran Hospital Department of Urology, Milwaukee, Wisconsin, 53226, United States; Recruiting
Robert Donnell, Principal Investigator
University of Wisconsin Medical School: Clinical Trials, Madison, Wisconsin, 53715, United States; Recruiting
David Paolone, MD, Principal Investigator
St. Michael''''s Hospital, Milwaukee, Wisconsin, 53209, United States; Recruiting
Mitchell Wiatrak, MD, Principal Investigator
Wyoming
Wyoming Research Foundation, Cheyenne, Wyoming, 82001, United States; Recruiting
John Bryant, MD, Principal Investigator
Robert S. Boger, M.D., Study Director, GTx
More Information
Last Updated: August 10, 2005
Record first received: August 9, 2005
ClinicalTrials.gov Identifier: NCT00129142
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-23
Resources
- (National Women's Health Information Center, OWH, HHS)
- 1999 Federal Government TTY Directory (Federal Citizen Information Center, GSA)

Not Signed In -


